Latest commercial agreement marks critical first step into US and Canadian healthcare markets as well as burgeoning new area of…
Read More
New results published at the world’s largest dementia conference further expand the scientific evidence around Cognetivity’s novel platform for early…
ICA’s remote capability and sensitivity to early-stage cognitive impairment key to role in new NHS clinic dedicated to enabling timely…
New paper provides further evidence of ICA’s sensitivity to early-stage Alzheimer’s Disease, freedom from cultural or educational bias and suitability…
Dubai launch grants access to wealthy and innovative national healthcare system, and provides stepping stone to rest of Middle East and enormous healthcare…
There is no excerpt because this is a protected post.
Former Director of Research at Alzheimer’s Research UK Carol Routledge joins advisory board at Cognetivity Neurosciences Dr Routledge brings extensive…
There is no excerpt because this is a protected post.
Newly-filed patent will enable platform technology to be licensed for much-needed biomarker assessment in pharmaceutical and healthcare industries VANCOUVER, BC, June…
Ed Smith brings experience in a range of top advisory roles across the UK’s public and private healthcare sectors VANCOUVER,…
